Welcome
Please select your view
Dr Linda Dreyer completed her undergraduate studies in 1996, receiving a Bachelor’s degree in Medicine and Surgery (MBChB) from the Faculty of Health Sciences, University of Pretoria, South Africa.
Following four years of clinical practice, as Medical Officer in the Department of Family Medicine she commenced specialisation in 2000. She was appointed as Registrar in Clinical Virology at the University of Pretoria/ Gauteng Province where she worked for two years and in 2003 she was appointed as Senior Registrar in Microbiology.
Dr Dreyer received her Master’s degree in Clinical Microbiology (MMed (Path)) from the University of Pretoria in 2006. She worked as a consultant for the National Health Laboratory Services (NHLS) in Pretoria until January 2008. During her time at NHLS she was involved in teaching medical students and microbiology registrars and gave lectures to nursing staff, medical students and specialists. She also sat on the Infection Control Committee and the Antimicrobial Stewardship Committee of the Pretoria Academic Hospital.
She came to Melbourne and joined Australian Clinical Labs (formerly Healthscope Pathology) in 2008 as a Senior Registrar and obtained Fellowship of The Royal College of Pathologists of Australasia (FRCPA) in 2010.
Dr Dreyer has special interests in the appropriate use of antimicrobials, infection control and molecular diagnostic assays in contemporary clinical microbiology.
Dr Stella Pendle completed a Master of Science degree in 1983 prior to graduating in Medicine from the University of the Witwatersrand, Johannesburg. She initially worked at the Hillbrow Hospital in Johannesburg and then at the Rietfontein Tropical Diseases Hospital. She obtained a Diploma in Tropical Medicine during this time. In 1999, Stella emigrated to Australia and worked as a resident at Gosford Hospital after completing the AMC exams. She proceeded to specialist training in Pathology (Microbiology) at Royal North Shore Hospital and ICPMR Westmead.
On completion of her training, she moved to Symbion Laverty Pathology where she worked for four years as a Clinical Microbiologist. In 2009, she joined Pathology NSW as the supervising pathologist in charge of the microbiology, infectious serology and molecular diagnostics departments. She has continued in this role after the company merged with Australian Clinical Labs (formerly Healthscope Pathology).
Dr Pendle has published several papers in her fields of interest, including VRE, chlamydial infections and HIV. She actively participates in Infection Control and promotes rational antibiotic prescribing at Healthscope Hospitals. She is a member of the Australian Society for Microbiology, the Australasian Society for Infectious Diseases and the Antimicrobial Society of Australia.
Dr Stanford graduated from the University of New South Wales in 2005. She completed Basic Physician Training, followed by Advanced Training in Chemical Pathology and Endocrinology. This included undertaking a year with a focus on bone disease at St Vincent’s hospital (Sydney), followed by a year of general clinical endocrine training at Prince of Wales Hospital.
Dr Stanford then completed her joint training based at the Prince of Wales and Royal North Shore Hospital Laboratories. In 2019, she was awarded fellowship of both the Royal Australasian College of Physicians and The Royal College of Pathologists of Australasia.
Dr Stanford then worked at Tan Tock Seng hospital laboratory in Singapore before returning to Australia to take up a Chemical Pathologist position at Australian Clinical Labs.
Dr Sudha Pottumarthy-Boddu comes to us from Houston, Texas, where she was Assistant Professor in the Department of Pathology and Laboratory Medicine at the University of Texas, School of Medicine. She was also the Technical Director of the Clinical Laboratory Services at the Houston Department of Health and Human Services.
After graduating from medical school in India, Dr Pottumarthy-Boddu migrated to New Zealand and completed her Pathology/Microbiology Fellowship training with the Royal College of Pathologists of Australasia. She is a recipient of various awards and scholarships, including the Neil Prentice Memorial Prize of RCPA. She is also a Diplomate of the American Board of Medical Microbiology.
Over the last 10 years she gained experience in various hospital, research, and public health laboratories in the US, publishing over 30 articles in peer-reviewed journals and presenting at various national and international conferences. Detection of the first USA isolate of Enterobacter spp., with NmcA carbapenem hydrolyzing enzyme and establishing clinical significance of Nocardia verterana are noteworthy. Dr Pottumarthy-Boddu’s main research interests are antimicrobial susceptibility trends and molecular methods in the diagnosis of infectious diseases.
Dr Tony Mak is a chemical pathologist who graduated from the medical school of the Chinese University of Hong Kong. Before migrating to Australia, Tony worked as a consultant chemical pathologist at Princess Margaret Hospital – a major acute district general hospital in Hong Kong.
Tony founded, developed, and operated the highest level clinical toxicology laboratory in Hong Kong. He led his team to develop numerous useful analyses to solve many difficult clinical toxicology problems with public health implications, including Chinese medicine related poisoning, plant-related poisoning, novel psychoactive substances, slimming agents and related problems, drug adulteration and counterfeit drugs.
Tony held numerous management roles in Hong Kong including Head of the Department of Pathology, Service Director (Quality and Safety) and Deputy Hospital Chief Executive. He has published more than 100 articles in international peer-reviewed academic journals and a number of books.
We are excited to announce Tony’s new role as Clinical Director, Chemical Pathology for Clinical Labs in WA.
Following the July 2025 MBS update, Dr David Deam outlines a new diagnostic pathway for vitamin B12 testing, emphasising clinical vigilance for timely and accurate diagnosis.
Best Practice for Specimen Collection – Preventing Recollects and Result Delays
Assoc. Prof. Chris Barnes outlines key annual blood tests for men and addresses common barriers to proactive health management.
Melaseq is an Australian-developed and owned test that enables doctors to more accurately diagnose melanoma in its earlier stages.